Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Providers
Mary-Rachel McCabe
MaryRachel_McC
1/ Today's three reports from the @ChildrensComm on children in care pull no punches.https://www.childrenscommissioner.gov.uk/2020/11/11/thousands-of-children-in-care-being-failed-by-the-state-because-of-a-broken-residential-care-home-m
Read more
Will Beeson
will_beeson
1/ I talked to @mpmassaro and @mattcharris recently on @rebankpodcast about embedded finance and want to share some thoughts. 2/ @BainCapVC believes we’re in the midst of a platform shift
Read more
Devon Price
drdevonprice
Therapy isn't for everyone. Or to put it more pointedly, *therapists* aren't for everyone. Most therapists are white, well-off cis women trained to work with people very much like themselves.
Read more
Beverley Miles
BeverleyBMiles
A/Prof @Lan_Snell kicking of #GlobalMBA curriculum series in discussion with @AdamBrimo @openlrning + Fiona Reay from @coursera & @ProfBevOliver https://macq.it/31MtOHB #qanda #academicchatter #highered #edflix #edtech #femedtech #
Read more
Rob Cottingham
RobCottingham
In which I argue that Star Trek may have saved countless lives in British Columbia. [thread] No question, the credit for BC’s curve-flattening COVID-quashing performance has to go first to
Read more
Timothy B. Lee
binarybits
People seem to think this is a compelling argument against antitrust enforcement but it's really not. Anyone familiar with economic history knows that new high-tech industries tend to have a
Read more
Liz Szabo
LizSzabo
@DrPaulOffit tells @JAMA_current he was totally surprised that both mRNA vaccines have 94-95% efficacy. In January, he said, "no one would have thought this was possible."#JAMAlive In his live interview,
Read more
Elizabeth Yin
dunkhippo33
8) For this reason, I often feel like the advice that VCs give to B2B SaaS companies to step on the gas prematurely and spend like crazy w/ out figuring
Read more
Eric Secemsky MD MSc
EricSecemskyMD
PACLITAXEL TWEETORIAL1/Brief tweetorial to provide context of the importance of today's NEJM paper showing no mortality difference at 1-4 years between patients with peripheral artery disease treated with paclitaxel-coated (PCD)
Read more
Rachel Sachs
RESachs
The most-favored nation drug pricing rule is now out. I will have a blog post up later going into greater detail about the rule (here’s a link to the post
Read more
Drew Harwell
drewharwell
Bad news for Parler: They've gotten ditched by Apple, Google, Amazon, text message services and email providers. Other bad news: Their lawyers left, too https://deadline.com/2021/01/parler-ceo-says-service-dropped-by-every-vendor-and-co
Read more
Martin Barrow
MartinBarrow
A document has come across my desk from Oxfordshire County Council, with opportunities for private providers of foster care and children’s homes. Not confidential, but not widely circulated. An insight
Read more
Marshall 📊🚑🌹
medic_marsh
I’ve only followed this topic on the periphery - but is this really just about the use of Ketamine? Or are we missing a bigger point? A ...https://twitter.com/emsworldofcl/status/1337727653160374273 Something I
Read more
jack_kelly
jack_kelly
The evolution from DNO to DSO requires a lot of new software to be written. Instead of each DNO re-inventing the wheel (and each spending £100s of millions on IT
Read more
Liz Hamel
lizhamel
Today we launch the KFF COVID-19 Vaccine Monitor, an ongoing project tracking the public’s attitudes and experiences with #COVID19 vaccinations. Here are some takeaways from the first survey 1/https://www.kff.org/coronavirus-covid-19/repo
Read more
Bobby Ong
bobbyong
Algorithmic stablecoins have been one of the most exciting parts of crypto recently. The design space is wide and there have been many innovations taking place. I have been following
Read more
‹
1
2
...
42
43
44
45
46
47
48
...
108
109
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree